A Clinical trial on Meni Lavana Chooranam in the management of Vatha Gunmam(Peptic Ulcer Disease) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, Palayamkottai.

A prospective open labelled, single arm, non-randomized, single centric, phase II clinical trial to determine the effectiveness of Meni Lavana Chooranam in the management of Vatha Gunmam (Peptic Ulcer Disease) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085436

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: Meni Lavana chooranam: DOSAGE:1 gram twice a day orally for 40 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of Abdominal pain constipation vomiting indigestion fatigue and weakness body pain headache dizziness xerostomia Patients are willing to take upper gastro intestinal endoscopy

Exclusion criteria

Exclusion criteria: CA Stomach Cardiac disease Appendicitis Cholelithiasis Pregnancy& lactation

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of Vatha gunmam(Peptic Ulcer Disease) and to determine the therapeutic efficacy of clinical trial drug(Meni Lavana chooranam)Timepoint: 40 days	—

Secondary

Measure	Time frame
Evaluation of additional effects and siddha parametric changes in vatha gunmamTimepoint: 40 days	—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli Alias Mehala

Government Siddha Medical College and Hospital

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026